
...


By Matthew Robinson and Alia Shoaib
0
Share
Newsweek is a Trust Project member
See more of our trusted coverage when you search.Prefer Newsweek on Googleto see more of our trusted coverage when you search.
Israel's Prime Minister Benjamin Netanyahu has revealed he underwent successful treatment for early-stage prostate cancer after doctors discovered a small malignant tumor, with the publication of his annual medical report delayed by two months so as not to give Iran the chance to “spread even more false propaganda against Israel,” he said.
In a post on X on Friday, Netanyahu wrote he had undergone treatment at the Hadassah Medical Center in Jerusalem, which had "removed the problem and left no trace of it."
Why It Matters
The revelation about Netanyahu’s health comes amid Israel’s ongoing confrontation with Iran and its proxies and allies, including Lebanon, and raises questions about a possible successor should Netanyahu be unable to continue. While fighting is paused under fragile ceasefires, tensions remain high in the region.
Read More on News
In his statement, Netanyahu explicitly linked the timing of his health disclosure to the broader conflict, saying he delayed publication of his medical report to avoid giving Iran ammunition for “propaganda.”
What To Know
The prime minister wrote Friday that a year-and-a-half ago he underwent successful surgery for an enlarged benign prostate and remained under routine medical monitoring.
"In the last monitoring, a tiny spot of less than a centimeter was discovered in the prostate. Upon examination, it turned out to be a very early stage of a malignant tumor, with no spread or metastases whatsoever," he wrote.
Netanyahu said doctors gave him two options, either to leave it untreated and remain under monitoring, as many others do, or to have it removed.
“When I'm given information in time about a potential danger, I want to address it immediately. This is true on the national level and also on the personal level. That's what I did,” the prime minister wrote.

...
Netanyahu said he underwent “targeted treatment” after which “the spot disappeared completely.”
He said he requested the publication of his annual medical report to be delayed by two months so that “it would not be released at the height of the war” in order to prevent “the Iranian terror regime to spread even more false propaganda against Israel.”
The prime minister ended his post by encouraging Israelis to get checked and follow doctors’ instructions.
Prostate Cancer Dangers
Prostate cancer is the fourth most common cancer worldwide, and the second most common cancer in men.
It is often highly treatable when detected early and has relatively low mortality rates compared with many other cancers, with early-stage survival close to 100 percent, according to the World Cancer Research Fund (WCRF).
A “first-stage” or very early-stage malignant tumour in the prostate usually refers to cancer that is small and localized to the prostate gland, meaning it has not spread to the lymph nodes or other organs.
Treatment options can include radiation therapy, targeted focal therapy, or, in some cases, surgery.
Netanyahu’s comment that he “went to a few short treatments, read a book, and continued working,” suggests he underwent a minimally invasive treatment.

...
Netanyahu's Medical History
Netanyahu has undergone several medical procedures in recent years that have been publicly disclosed.
In 2023, he had a pacemaker implanted after a heart monitor fitted following a hospitalization for dehydration detected a “transient heart block.”
In early 2024, he underwent surgery to repair a hernia discovered during a routine check-up.
And in December of that year, he had prostate surgery to treat benign enlargement following a urinary tract infection. The medical report released following the surgery that there was no indication of prostate cancer.
What Happens Next
Netanyahu said he is in good health, and the news is not expected to affect his official duties. He will likely continue routine medical monitoring following the successful treatment of the tumor.
Update 4/24/26, 9:38 a.m. ET: This article has been updated with additional information.
Update 4/24/26, 10:37 a.m. ET: This article has been updated with additional information.
View 0 Comments
Submit Correction
View Editorial & AI Guidelines